FABP4 and metabolic syndrome: Further studies are needed with larger sample sizes, within the whole cohort of the population, and may include examining FABP4 levels in different stages of pregnancy, especially postpartum, and then conducting a long-term follow-up to explore whether postpartum FABP4 levels play a role in predicting future metabolic syndrome and cardiovascular disease.